• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Skin Cancer Treatment Drugs Markets in China - Product Image

Skin Cancer Treatment Drugs Markets in China

  • ID: 1195413
  • June 2014
  • Region: China
  • 201 pages
  • AMID Co
China's demand for Skin Cancer Treatment Drugs will continue to grow at about 5% by 2023.

China's demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented.

Major producers in China are profiled. A selection of these companies can be seen in the 'Companies Mentioned' tab. The full list can be viewed upon purchase of the report.

China's demand for Skin Cancer Treatment Drugs will continue to grow at about 5% by 2023.

TABLE OF CONTENTS

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. SKIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Skin Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Driver
Skin Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations
Major Producer Sales Volume and Market Share
Fluorouracil
Bleomycin
Cisplatin
Mitomycin
Retinoids
a-Interferon
Interleukin
Cancer vaccines inhibitors
Photosensitizing Agents
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Overview
Sales Volume of Skin Cancer Treatment Drugs by Region
Skin Cancer Treatment Drugs Sales Volume
Chemotherapy Drugs Sales Volume
Fluorouracil
Bleomycin
Cisplatin
Mitomycin
Retinoids
Immunotherapy Drug
a-Interferon
Interleukin
Cancer Vaccines
Photodynamic Therapy Drugs
Skin Cancer Treatment Drugs Imports and Exports
Skin Cancer Treatment Drugs Imports
Skin Cancer Treatment Drugs Exports
Pricing Trends

V. SKIN CANCER TREATMENT DRUGS MARKET OUTLOOK

Skin Cancer Treatment Drugs Market Outlook Overview
Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview
China’s Distribution System
Skin Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprise

VII. SKIN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Skin Cancer Treatment Drugs Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. SKIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Skin Cancer Treatment Drugs Sales Volume and Market Share by Drugs Classification
Skin Cancer Treatment Drugs Sales Volume
Major Producer Facility Location
Major Skin Cancer Treatment Drugs Producer Sales Volume
Major Foreign Investment in China

IV. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Skin Cancer Treatment Drugs Sales Volume
Demand of Skin Cancer Treatment Drugs by Region
Chemotherapy Drugs Sales Volume and Market Share by Drugs Classification
Fluorouracil Sales Volume
Fluorouracil Major Producer and Their Market Share
Bleomycin Sales Volume
Bleomycin Major Producer and Their Market Share
Cisplatin Sales Volume
Cisplatin Major Producer and Their Market Share
Mitomycin Sales Volume
Mitomycin Major Producer and Their Market Share
Retinoids Sales Volume
Retinoids Major Producer and Their Market Share
Immunotherapy Drugs Sales Volume and Market Share by Drugs Classification
a- Interferon Sales Volume
a- Interferon Major Producer and Their Market Share
Interleukin Sales Volume
Interleukin Major Producer and Their Market Share
Cancer Vaccines Sales Volume
Cancer Vaccines Major Producer and Their Market Share
Photodynamic Therapy Drugs Sales Volume and Market Share by Drugs Classification
China’s Skin Cancer Treatment Drugs Imports and Exports

V. SKIN CANCER TREATMENT DRUGS MARKET OUTLOOK

Skin Cancer Treatment Drugs Sales Volume
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

China’s Skin Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Specialty Output by Ownership
China’s Imports and Exports

III. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Skin Cancer Treatment Drugs Sales Volume by Drugs Classification
Skin Cancer Treatment Drugs Sales Volume in China

IV. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Skin Cancer Treatment Drugs Sales Volume in China
Skin Cancer Treatment Drugs Sales Volume by Type
Chemotherapy Drugs Sales Volume
Chemotherapy Drugs Sales Volume by Drugs Classification
Fluorouracil Sales Volume
Bleomycin Sales Volume
Cisplatin Sales Volume
Mitomycin Sales Volume
Retinoids Sales Volume
Immunotherapy Drugs Sales Volume
Immunotherapy Drugs Sales Volume by Drugs Classification
a- Interferon Sales Volume
Interleukin Sales Volume
Cancer Vaccines Sales Volume
Photodynamic Therapy Drugs Sales Volume
Photodynamic Therapy Drugs Sales Volume by Drugs Classification
Growth Factor Inhibitors Sales Volume
Total Skin cancer treatment drugs Import and Export

V. SKIN CANCER TREATMENT DRUGS MARKET OUTLOOK

Skin Cancer Treatment Drugs Sales Volume

VI. MARKETING STRATEGIES

China’s Distribution Channel

China's demand for Skin Cancer Treatment Drugs will continue to grow at about 5% by 2023.

- Jiangsu Hengrui Medicine Co., Ltd.
- Bristol-Mysers Squibb (Shanghai) Co., Ltd.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos